FOR IMMEDIATE RELEASE: 80+ Organizations Urge Trump Administration to Cut Spending & Reward Innovation by Expanding Access to Obesity Medications A Centers for Medicare & Medicaid Services (CMS) Proposed Rule Would Address Outdated Policy Constraints & Expand Access to Innovative Treatments for Obesity Tampa, FL (April 3, 2025) — Today, the Obesity Action Coalition (OAC)
Read Article

As Obesity Care Week (OCW) 2025 continues, we at the Obesity Action Coalition (OAC) can’t emphasize enough the power of collaboration in driving meaningful change for individuals affected by obesity. As a Founding Champion of OCW, we’re invested in advancing obesity care, fighting stigma and advocating for stronger policies. Our impact is amplified through our
Read Article

Under current law, Medicare’s prescription drug benefit (Part D) excludes “agents when used for anorexia, weight loss, or weight gain”. This exclusion has prevented Medicare from covering obesity medications and has allowed Medicaid plans to opt out of providing such coverage. For more than a decade, the OAC has pursued both legislative and regulatory pathways
Read Article

Congress must support bipartisan legislation that will ensure Medicare beneficiaries can access safe, effective, and life-saving treatments for obesity. Update: On November 26th, the White House announced a to expand coverage for obesity medications under Medicare and Medicaid. Click here to learn more about what this means for patients.  The Treat and Reduce Obesity Act
Read Article